During chronic viral infections and in cancer, T cells become dysfunctional, a state known as T cell exhaustion. Although it is well recognized that memory CD8 T cells account for the persistence of CD8 T cell immunity after acute infection, how exhausted T cells persist remains less clear. Using chronic infection with lymphocytic choriomeningitis virus clone 13 and tumor samples, we demonstrate that CD8 T cells differentiate into a less exhausted TCF1
INTRODUCTION
In response to immunization or acute infection, T lymphocytes differentiate into functional effector cells and develop immunological memory (1, 2) . However, during cancer and chronic viral infections such as HIV, prolonged antigen exposure and immunosuppression undermine the efficacy of T cell responses, leading to a state called T cell exhaustion (3) . T cell exhaustion is characterized by progressive loss of effector functions, reduced proliferative capacity, and failure of memory differentiation (4) . This process is progressive: CD8 T cells early after chronic viral infection can still develop into memory cells, whereas those from the chronic phase of infection cannot (5) . Exhausted T cells express a range of inhibitory receptors, including PD1, CTLA4, Tim3, CD244, and LAG3, which mediate intracellular signals contributing to poor T cell responsiveness (3, (6) (7) (8) (9) (10) . Antibody blockade targeting inhibitory receptors, most prominently PD1 and CTLA4, has achieved major success in reversing T cell exhaustion in patients (11)-combined blockade of PD1 and receptors, such as Tim3, further improves therapeutic benefits (12, 13) . Cytokines, such as interleukin-10 (IL-10) (14) and type I interferon (IFN) (15, 16) , also affect T cell exhaustion. A recent study showed that type I IFN represses de novo generation of T helper 1 (T H 1) cells during chronic viremia (17) . However, the effects of type I IFN on CD8 T cells during chronic infection remain unclear.
How exhausted T cells are maintained, particularly whether exhausted T cells are capable of self-renewal or whether a stem cell-like T cell population repopulates exhausted cells, is not well understood.
Although CD8 T cells responding to acute infections are known to be diverse, containing memory precursors and terminal effectors (2) , the heterogeneity of exhausted CD8 T cells is less well appreciated. During chronic infection by lymphocytic choriomeningitis virus (LCMV) clone 13, blocking PD1 selectively expands a PD1 int CD8 subset, which is less exhausted than PD1 high counterparts (18) . Other studies have shown that exhausted CD8 T cells can be separated into a T-bet high progenitor population and an Eomes high terminal population (19) . However, these studies mostly examined the chronic phase of viral infection. Whether there is earlier bifurcation of progenitor-like and more terminally differentiated CD8 subsets remains unclear.
The transcription factor TCF1 is crucial for the differentiation of various mature T cell subsets, including T central memory (T CM ) (20) and T follicular helper (T FH ) cells (21) (22) (23) . T FH cells persist better than do T H 1 cells during chronic viral infection (24) , suggesting a potential role of TCF1 in sustaining antiviral T cell responses during persistent infection. We demonstrate here that CD8 T cells differentiate into TCF1 high and TCF1 low subsets during both chronic viral infection and cancer. Virus-specific TCF1 high CD8 T cells, which transcriptionally resemble T FH cells, express lower levels of exhaustion markers such as Tim3, persist better, and mount a stronger recall response than do TCF1 low CD8 T cells. TCF1
high Tim3 low cells act as progenitor cells that either remain as progenitors or terminally differentiate into TCF1 low Tim3 high cells. We further demonstrate that differentiation of this progenitor-like CD8 subset is driven by TCF1 and repressed by type I IFN in a cell-autonomous manner. Mechanistically, TCF1 represses expression of Blimp1, Tim3, and Cish while promoting expression of Bcl6, which increases the progenitor-like CD8 T cell population. Thus, we have identified a TCF1 high progenitor CD8 subset, which is critical for sustained antiviral T cell responses and is programmed by an interplay between type I IFN and the TCF1-Bcl6 axis early after chronic viral infection.
RESULTS

TCF1
high Tim3  low and TCF1   low   Tim3  high CD8 T cells in chronic  LCMV infection resemble T FH and T H 1 cells  During acute LCMV infection, virus-specific CD4 T cells can be  separated into CXCR5   high   TCF1  high T FH and CXCR5   low   TCF1 low T H 1 subsets, which express reciprocal levels of Blimp1 (21) (22) (23) S1, A and B) . TCF1 promotes the differentiation of memory CD8 T cells (20, 26, 27) , whereas Blimp1 drives CD8 T cell exhaustion during chronic viral infection (28) . Like CD4 T cells, we found that virus-specific CD8 T cells (identified by either H-2Db GP276 tetramer or H-2Db GP33 tetramer staining) could be divided into two distinct subsets on the basis of expression of TCF1, on day 7 of chronic LCMV infection (Fig. 1A  and fig. S1C ). TCF1 low CD8 T cells were more abundant and expressed higher levels of both Blimp1 and Tim3. In contrast, TCF1 high cells constituted less than 20% of virus-specific CD8 T cells and expressed much less Tim3 and Blimp1. Four weeks after infection, TCF1 low Tim3 high Blimp1 high CD8 T cells still made up the majority of virus-specific CD8 T cells (Fig. 1B and fig. S1D ) and had further down-regulated TCF1 to levels similar to those in B cells, which do not express TCF1. Thus, virus-specific CD8 T cells differentiate into  TCF1  high Tim3   low   Blimp1  low and TCF1   low   Tim3 high Blimp1 high subsets early after infection with LCMV clone 13, even before T cell exhaustion has been fully established (5 fig. S1 , F and G). This difference became more evident 4 weeks after infection (Fig. 1D and fig. S1H ). To determine whether TCF1 high CD8 T cells resemble T FH cells on a transcriptome level, we performed Gene Set Enrichment Analysis (GSEA) on our microarray data using previously described T FH and T H 1 signature gene sets from LCMVinfected mice (21) . The T FH gene signature was strongly enriched in Tim3 low Blimp1 low (TCF1 high ) CD8 T cells, whereas almost all T H 1 signature genes were up-regulated in Tim3 high Blimp1 high (TCF1 low ) CD8 T cells (Fig. 1E) . GSEA using Kyoto Encyclopedia of Genes and Genomes (KEGG) and Reactome curated pathway databases revealed that Tim3 low Blimp1 low CD8 T cells exhibited enrichment of genes related to branched-chain amino acid degradation ( fig. S1I ), similar to T FH cells (21) . Enrichments of ribosome and type I IFN signaling pathways were also observed ( fig. S1I) . Thus, the bifurcation of TCF1 high and TCF1 low virus-specific CD8 T cells after chronic LCMV infection shows notable similarities with T FH and T H 1 CD4 T cells after acute viral infection.
high Tim3 low marks a less exhausted T cell population in chronic viral infection and cancer Tim3 low Blimp1 low CD8 T cells exhibited higher mRNA levels of Tnfrsf4, encoding OX40, a costimulatory receptor that enhances T cell survival during chronic viral infection (Fig. 1C) (29) . In contrast, besides Havcr2 (encoding Tim3) and Prdm1 (encoding Blimp1), Tim3 high Blimp1 high CD8 T cells had higher expression of other genes associated with T cell exhaustion, including Cd244, Il10, and Cish (Fig. 1C and table S1 ) (30) . Evaluation of protein confirmed that TCF1 high CD8 T cells expressed lower levels of surface 2B4 and LAG3, despite having slightly higher surface PD1, on day 7 after infection ( Fig. 2A and fig.  S2A ). By 4 weeks after infection, PD1, 2B4, and LAG3 were all lower on TCF1 high CD8 T cells compared with their TCF1 low counterparts (Fig. 2B and fig. S2B ). Thus, TCF1
high CD8 T cells appear less exhausted than the TCF1 low population, especially after infection progresses to chronic phase.
To address whether TCF1 expression inversely correlates with T cell exhaustion in other models, we implanted C57BL/6 mice with 3-methylcholanthrene-induced fibrosarcoma (MCA205) cells and examined tumor-infiltrating lymphocytes (TILs). CD8 TILs could be readily separated into TCF1 high and TCF1 low populations (Fig. 2C) , with TCF1 low CD8 T cells exhibiting higher PD1, Tim3, 2B4, and LAG3 ( Fig. 2C  and fig. S2C ). Furthermore, most PD1 high Tim3 low cells expressed low levels of TCF1 ( fig. S2D ). However, most Tim3 low CD8 TILs did not express high CXCR5, unlike virus-specific CD8 T cells during chronic LCMV. Similarly, PD1 levels in CD8 TILs from melanoma patients also correlated negatively with TCF1 expression and positively with Tim3 expression (Fig. 2D) . Thus, reduced TCF1 expression appears to be a universal hallmark of T cell exhaustion during both chronic viral infection and cancer.
Because high CD8 T cells from day 7 infected C57BL/6 mice into naïve CD45.1 mice that were then infected with LCMV clone 13. After 7 days, there were about sixfold more of both total and tetramer + donor CD8 T cells in mice that had received Tim3 low CD8 T cells (Fig. 2E) , and (D) are representative of at least two independent experiments with n ≥ 3. Statistical significance was determined by paired t tests. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Microarrays (C and E) were performed with three biological replicates per group. ES, enrichment score; FDR, false discovery rate. are representative of three melanoma patients. Statistical significance was determined by paired (A and B) and unpaired t tests (E to G). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. (21) , in which TCF1 is efficiently deleted in mature T cells, with LCMV clone 13. On day 7 after infection, virus-specific CD4 T cell numbers were comparable between WT and cKO mice ( fig. S3A ), although loss of TCF1 reduced the frequency and number of virus-specific T FH cells ( fig. S3B ). In the CD8 compartment, TCF1 deficiency mildly reduced numbers of virus-specific T cells (Fig. 3A and fig. S3C ). However, the Tim3 low population virtually disappeared in tetramer + CD8 T cells in TCF1-deficient mice (Fig. 3B and fig. S3D ). Thus, TCF1 is required for the programming of Tim3 low virus-specific CD8 T cells early during LCMV clone 13 infection. In addition, TCF1-deficient virus-specific CD8 T cells expressed higher 2B4 (fig. S3, E and F), suggesting that these cells exhibited characteristics of T cell exhaustion. Nonetheless, viral titers in the blood and spleen of TCF1-deficient mice were not significantly higher than those of WT on day 7 after infection (fig. S3, G and H).
We then examined the effect of TCF1 deficiency during the chronic phase of LCMV clone 13 infection. The loss of TCF1 caused a severe reduction in the frequencies and numbers of both virus-specific CD4 (Fig. 3C ) and CD8 T cells (Fig. 3D and fig. S3I ). Thus, antiviral T cell responses during chronic viremia could not be sustained without TCF1. In addition, cKO CD8 T cells exhibited higher average levels of Tim3, PD1, and 2B4 (Fig. 3, E to G, and fig. S3J ), suggesting that the remaining virus-specific CD8 T cells were more exhausted. Consistent with these observations,~5-fold less CD4 and >20-fold less CD8 T cells in cKO mice produced IFN-g after restimulation with class II-or class Irestricted LCMV-derived peptide epitopes ( fig. S3K ), respectively, with less IFN-g produced per cell ( fig. S3L ). Moreover, cKO mice had~10-fold higher viral titers in the blood and~100-fold higher viral titers in the spleen than their WT counterparts (Fig. 3H) .
By 3 months after infection, LCMV-specific CD8 T cells were almost undetectable in TCF1 cKO mice; LCMV-specific CD4 T cells in these mice were also greatly diminished (Fig. 3, I and J, and fig.  S3M ). Although remaining in brain and kidney, LCMV clone 13 is typically cleared from spleen and blood 3 months after infection (25) . Consistent with their lack of antiviral T cell responses, high levels of virus were found in blood from cKO mice (Fig. 3K) . Therefore, TCF1 is indispensible for sustained T cell responses during chronic viremia.
TCF1 is intrinsically required for persistence of virus-specific T cells during chronic viral infection
To address cell-intrinsic requirements for TCF1 in virus-specific T cells during chronic infection, we transplanted lethally irradiated WT CD45.1 mice with mixed bone marrow from WT CD45.1 donors and CD45.2 donors that were either WT or Tcf7 cKO. In these chimeras, WT and cKO T cells were exposed to the same environment, allowing their direct comparison. Seven days after infection, there were no significant differences in the frequencies of either virus-specific CD4 ( fig. S4A) or CD8 (Fig. 4A and fig. S4B ) T cells between WT and cKO T cell compartments in chimeras. Thus, the initial expansion of virusspecific T cells after clone 13 infection did not require intrinsic TCF1 function. Nonetheless, TCF1 was indispensible for the generation of Tim3 low virus-specific CD8 T cells in a cell-autonomous manner; frequencies of Tim3 low cells were notably lower within virus-specific cKO CD8 T cells than within WT CD8 T cells in the same mice (Fig.  4B and fig. S4C ).
However, by 4 weeks after infection, the frequencies of tetramer + CD4 T cells within cKO CD4 T cell compartments were considerably less than those within the WT compartments in chimeras ( fig. S4D ).
The impact of TCF1 deficiency appeared even more profound in CD8 T cells: Frequencies of virus-specific CD8 T cells within cKO donor-derived CD8 T cells were sharply reduced relative to those within WT donor-derived CD8 T cells (Fig. 4, C and D, and fig. S4E ). Frequencies of cKO CD8 T cells that produced IFN-g in response to GP276 or GP33 peptide restimulation were also significantly lower than those of WT ( Fig. 4E and fig. S4F ). Nonetheless, viral titers did not differ between the two types of mixed chimeras, because WT cells were present in each case ( fig. S4G ). Thus, long-lasting antiviral T cell responses, especially those mediated by CD8 T cells, require TCF1 in a cell-autonomous manner.
Enforced expression of TCF1 enhances the generation of Tim3 low CD8 progenitor cells sustaining long-lasting antiviral CD8 T cell responses To determine whether TCF1 is sufficient to drive the differentiation of Tim3 low virus-specific CD8 T cells, we transduced P14 T cell receptor (TCR) transgenic CD8 T cells, which recognize the GP33 epitope of LCMV (31), with MSCV (murine stem cell virus)-IRES (internal ribosomal entry site)-GFP (green fluorescent protein) (MIG) retroviral vectors that either did or did not encode TCF1. Transduced cells were transferred into naïve C57BL/6 recipients that were immediately infected with LCMV clone 13. On day 8 after infection, TCF1 overexpression strongly increased the percentages of Tim3 low P14 cells (Fig. 5A) . Although only~10% of control P14 cells were CXCR5 high Tim3 low , this subset constituted >30% of TCF1-overexpressing P14 cells (Fig. 5B) . TCF1 overexpression also enhanced Bcl6 expression (Fig. 5C ). Furthermore, whereas numbers of control and TCF1-overexpressing P14 cells were comparable on day 8 after infection ( fig. S5A ),~10-fold more TCF1-overexpressing P14 cells were recovered relative to controls on day 14 after infection (Fig. 5D) . Therefore, TCF1 overexpression both drives the differentiation of a T FH -like CD8 progenitor population and enhances long-term persistence of virus-specific CD8 T cells during chronic viral infection.
TCF1 orchestrates a core network of genes regulating T cell differentiation To determine whether TCF1 globally redirected virus-specific CD8 differentiation after chronic LCMV infection, we sorted tetramer + WT and TCF1 cKO CD8 T cells on day 7 after infection and profiled their transcriptomes ( fig. S6A) (Fig. 6A) . In addition, TCF1 cKO CD8 T cells had reduced mRNA for transcription factors such as Aff3, Ikzf2, and Bcl6 and surface molecules such as Il23r, Cxcr5, Tnfsf8 (encoding CD30L), Sell (encoding CD62L), and Ccr7 (Fig. 6B and fig. S6B ). Aff3 is highly expressed by T FH cells and memory precursors (21) . CD30L is critical for the generation of long-lived memory CD8 T cells (32) . 
Blimp1
high signature (Fig. 6C) . Thus, TCF1 drives the differentiation of virus-specific CD8 T cells toward the Tim3 low Blimp1 low lineage on a global scale. Microarray data further revealed that many genes down-regulated by TCF1 deficiency (Fig. 6B) were up-regulated by TCF1 overexpression (Fig. 6D) . To examine whether TCF1 loss of function and gain of function perturbed expression of similar sets of genes, we generated four gene sets: genes downregulated or up-regulated by TCF1 overexpression and genes downregulated or up-regulated by TCF1 KO (tables S2 and S3). TCF1 cKO cells exhibited increased expression of genes down-regulated by TCF1 overexpression and decreased expression of genes up-regulated by TCF1 overexpression (fig. S6D) . Similarly, TCF1-overexpressing P14 cells showed enhanced WT-associated and reduced cKO-associated gene signatures ( fig. S6E) . Thus, TCF1 deficiency and TCF1 overexpression reciprocally affect the activity of the same core gene network. To explore pathways regulated by TCF1, we performed GSEA using the Reactome database and found that signatures related to branched-chain 
CD8 T cells 7 days after infection. (B) Representative histograms of Tim3 expression and frequencies of Tim3 low cells within H-2Db GP276 tetramer + WT and cKO CD8 T cells 7 days after infection. (C and D) Frequencies and numbers of WT and cKO I-Ab GP66 tetramer + CD4 (C) and H-2Db GP276 tetramer + CD8 (D) splenic T cells 4 weeks after infection. (E to G) Expression of Tim3, PD1, and 2B4 on H-2Db GP276 tetramer + splenic CD8 T cells from WT (blue) and cKO (red) mice 4 weeks after infection. (H) Viral titers in blood and spleens 4 weeks after infection. (I and J) Frequencies and numbers of WT and cKO I-Ab GP66 tetramer + CD4 (I) and H-2Db GP276 tetramer + CD8 (J) splenic T cells 3 months after infection. (K) Blood viral titers 3 months after infection.
Data are representative of at least two independent experiments with n ≥ 3. Statistical significance was determined by unpaired t tests. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
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amino acid degradation and transfer RNA aminoacylation pathways were up-regulated by TCF1 overexpression and down-regulated by TCF1 deficiency (fig. S6 , F and G). TCF1 deficiency also reduced branched-chain amino acid degradation genes in T FH cells, suggesting that a common metabolic signature is affected by TCF1 (21).
TCF1 directly regulates the Bcl6-Blimp1 axis and genes related to immune checkpoints Our microarrays showed that TCF1 down-regulates genes in multiple pathways mediating T cell exhaustion, including Havcr2 (Tim3), Prdm1 (Blimp1), and Cish (Fig. 6D) . In contrast, Bcl6, a master regulator of T FH cell differentiation that counteracts Blimp1 activity (33, 34) , was induced by TCF1 overexpression. (Fig. 6F) . TCF1 bound to a promoter region of Bcl6 important for Bcl6 expression in T FH cells (23) and showed stronger binding in Tim3 low than in Tim3 high CD8 T cells. Similarly, there was a greater enrichment of TCF1 binding at a major regulatory site in the third intron of Prdm1 (35) in Tim3 low CD8 T cells. TCF1 also preferentially bound to a region 7 kb upstream of Havcr2 transcription start site and to the promoter of Cish in Tim3 low cells. Both are potential regulatory regions based on published ATAC-seq (assay for accessible chromatin using high-throughput sequencing) and histone modification data (36) . Thus, TCF1 directly binds to regulatory regions of genes affecting CD8 T cell exhaustion. S1I ). Excessive type I IFN is induced early after chronic viral infection and drives T cell exhaustion (15, 16) . Type I IFN also inhibits T FH cell differentiation during acute viral infection (37) . The similarities between the bifurcation of TCF1
high and TCF1 low CD8 T cell fates during chronic viral infection Fig. 7, A to C, and fig. S7 , A to C) while reducing the number of TCF1 low Tim3 high cells (Fig. 7D and fig. S7D ). To determine whether the effects of type I IFN were CD8 T cell-autonomous, we transferred IFNAR1 KO and WT P14 cells mixed in 1:1 ratios into natural killer (NK)-depleted hosts that were subsequently infected with LCMV clone 13, because IFNAR1-deficient activated CD8 T cells are prone to NK cell-mediated killing (38, 39) . The percentage of TCF1 high Tim3 low cells within IFNAR1 KO P14 cells was greater than twofold higher than that within WT P14 cells on day 7 after infection ( Fig. 7E) . Similarly, knockdown of IFNAR1 increased the frequency of TCF1 high Tim3 low P14 cells (fig. S7E) . Moreover, TCF1 deficiency almost completely abrogated the effects of type I IFN blockade on Tim3 low CD8 T cells (Fig. 7F   and fig. S7F ), suggesting that these effects depended on TCF1. Thus, early programming of TCF1-dependent CD8 progenitors is suppressed by type I IFN signaling in a cell-autonomous manner.
DISCUSSION
Here, we demonstrate a bifurcation of CD8 T cell fates into a TCF1 high progenitor-like and a TCF1 low terminally differentiated population after chronic LCMV infection and in human and mouse tumors. Virus-specific TCF1 high Tim3 low CD8 T cells are less exhausted, persist and recall better, and act as progenitors that can either maintain their cell fate or differentiate into terminally differentiated TCF1 low cells. Moreover, TCF1 is both necessary and sufficient to program these CD8 progenitors early after LCMV clone 13 infection. In addition to suppressing expression of pro-exhaustion factors, such as Tim3, Cish, and Blimp1, TCF1 also up-regulates Bcl6, which strongly enforces the progenitor fate. Last, we found that type I IFN suppresses the differentiation of this progenitorlike CD8 subset in a cell-autonomous manner. Thus, we have found evidence for a CD8 progenitor population that is required for longlasting antiviral T cell responses and is governed by a type I IFN versus TCF1-Bcl6 axis early after chronic viral infection.
One of the most prominent features of TCF1 high Tim3 low CD8 T cells is their notable similarity with T FH cells both at the transcriptomic level and in the expression of the canonical T FH markers CXCR5 and Bcl6. We have shown that TCF1 acts upstream of Bcl6-Blimp1 axis in both T FH (21) and TCF1 high CD8 T cells, suggesting a possible shared mechanistic program. Moreover, given the requirement for TCF1 for memory CD8 cells, it is possible that a TCF1-driven program may be common to multiple lineages. Like T FH cells, TCF1 high Tim3 low CD8 T cells also express lower levels of canonical T H 1 markers, including Blimp1 (33) and Il2ra (40) . IL-2 signaling can repress virus-specific T FH differentiation via signal transducer and activator of transcription 5 (STAT5)-and Blimp1-mediated pathways (41, 42) , raising the possibility that IL-2 might also affect the differentiation of TCF1 low CD8 population and undermined long-term persistence of virus-specific CD8 T cells, further supporting the role of this population as progenitors that sustain long-term CD8 response. Our results are corroborated by papers published during the preparation of this article, which identified a CXCR5 + , TCF1-dependent stem cell-like CD8 population responsible for therapeutic effects of PD1 checkpoint blockade during chronic LCMV infection (43) (44) (45) . Our findings extend these studies by demonstrating a cell-intrinsic role for type I IFN signaling in suppressing these TCF1-dependent progenitor-like CD8 cells and by providing insight into TCF1-driven programs of gene expression. Furthermore, we now provide evidence for a parallel bifurcation of CD8 T cell populations in solid tumors, in both mice and humans.
Nonetheless, although we have shown that CD8 + TILs contain TCF1 high and TCF1 low subsets, we do not yet know the proportion of tumor-specific CD8 T cells within these subsets or whether TCF1 Data are representative of at least two independent experiments with n ≥ 3. Statistical significance was determined by unpaired t tests. **P < 0.01, ***P < 0.001, ****P < 0.0001.
cell follicles after LCMV-Docile infection and eliminates infected T FH cells (46) . However, we note that both TCF1 high and TCF1 low CD8 populations infiltrating MCA205 tumors exhibit low CXCR5 expression. The bifurcation of CD8 T cells into a less exhausted TCF1 high and a more exhausted TCF1 low population during chronic viral infection and cancer is therefore unlikely to be strictly dependent on B cell follicle homing or CXCR5 expression and thus may have broader implications for T cell exhaustion. by ChIP and quantitative reverse transcription polymerase chain reaction. Data in (E) and (F) are representative of two independent experiments with n ≥ 3. Statistical significance in (E) and (F) was determined by unpaired t tests. IgG, immunoglobulin G. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
MATERIALS AND METHODS
Study design
The goals of this study were to characterize a progenitor-like CD8 population during chronic LCMV infection and mouse and human cancers and to dissect the molecular pathways governing the differentiation of this population. Pilot experiments were performed to determine the number of replicates to ensure enough statistical power while minimizing animal usage. Each experimental group contained three to nine biological replicates. Statistical significance was defined by P < 0.05. Results were confirmed by at least two independent experiments.
Mice and infection Tcf7
loxP/loxP ; CD4-Cre (cKO) (21), Blimp1-YFP (47), P14 TCR transgenic mice recognizing LCMV GP33 (31) , and Ifnar1 KO P14 (38) were previously described. Animal husbandry and experiments were approved by the National Human Genome Research Institute (NHGRI), the National Institute of Neurological Disorders and Stroke (NINDS), or the National Cancer Institute (NCI) Animal Use and Care Committees, or by the authorization of the Landesamt für Natur, Umwelt und Verbraucherschutz NordrheinWestfalen in accordance with German laws for animal protection. For viral infections, age-and sex-matched mice were intravenously injected with 2 × 10 6 plaque-forming units (PFU) of LCMV clone 13. For type I IFN blockade, mice were injected intraperitoneally with 1 mg of anti-IFNAR1 (MAR1-5A3) 1 day before infection. For overexpression or knockdown studies, activated P14 CD8 T cells were spin-infected with retroviral constructs, sorted for transduced cells, and injected into C57BL/6 recipients, which were subsequently infected with LCMV. Viral plaque assay, antibody and tetramer (National Institute of Allergy and Infectious Diseases Tetramer Core Facility) staining, dyes, flow cytometry, and cell sorting are described in the supplementary materials and methods (48, 49) .
Human melanoma TIL Human samples were obtained as part of U.S. NCI Institutional Review Board-approved clinical trials (NCT01236573 and NCT01319565). Phenotyping is described in the supplementary materials and methods. 
Statistical analyses
Statistical analyses were conducted with GraphPad Prism 6 using two-tailed paired or unpaired Student's t tests. *P < 0.05, **P < experiments with n ≥ 3. Statistical significance in (B) to (D) and (F) was determined by unpaired t tests. Statistical significance in (E) was determined by paired t tests. *P < 0.05, ***P < 0.001, ****P < 0.0001.
0.01, ***P < 0.001, ****P < 0.0001. Bar graphs are represented as means + SD.
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